title: Recommendations for the long-term treatment of psoriasis with infliximab: a dermatology expert group consensus.
abstract: OBJECTIVE
  Infliximab has been approved for the treatment of chronic plaque psoriasis for only a few years. As physicians gain confidence in initiating and maintaining this therapy, guidance on the management of patients beyond several months or years is needed. To date, there is little or no information about the long-term management in clinical trials or guidelines.
  
  
  METHODS
  Here we report on the key aspects related to the use of infliximab for the treatment of psoriasis. The data presented here were derived using a modified Delphi survey to obtain a consensus opinion of 11 dermatologists from Europe and Canada experienced in long-term therapy with infliximab.
  
  
  CONCLUSIONS
  The Delphi participants reviewed several important topics related to biological therapy and infliximab. This paper is not intended to provide a recommendation on all practical aspects related to biological therapy; it has rather been written to provide useful and practical information on the 'best practice' use of infliximab.
authors.affiliation: Department of Dermatology, Dermatologikum Hamburg, Hamburg, Germany. reich@dermatologikum.de
authors.forename: Kristian
authors.initials: K
authors.lastname: Reich
authors.forename: Christopher
authors.initials: C
authors.lastname: Griffiths
authors.forename: Jonathan
authors.initials: J
authors.lastname: Barker
authors.forename: Sergio
authors.initials: S
authors.lastname: Chimenti
authors.forename: Esteban
authors.initials: E
authors.lastname: Daudén
authors.forename: Alberto
authors.initials: A
authors.lastname: Giannetti
authors.forename: Robert
authors.initials: R
authors.lastname: Gniadecki
authors.forename: Andreas
authors.initials: A
authors.lastname: Katsambas
authors.forename: Richard
authors.initials: R
authors.lastname: Langley
authors.forename: Ulrich
authors.initials: U
authors.lastname: Mrowietz
authors.forename: Alexandra
authors.initials: A
authors.lastname: Ogilvie
authors.forename: Jean-Paul
authors.initials: JP
authors.lastname: Ortonne
authors.forename: Norbert
authors.initials: N
authors.lastname: Reider
authors.forename: Jean-Hilaire
authors.initials: JH
authors.lastname: Saurat
mesh_terms: D000465:Algorithms; D000911:Antibodies, Monoclonal / Q000008:administration & dosage*; D003697:Delphi Technique; D003879:Dermatologic Agents / Q000008:administration & dosage*; D006801:Humans; D000069285:Infliximab; D011565:Psoriasis / Q000188:drug therapy*; D011795:Surveys and Questionnaires
chemical_list: D000911:Antibodies, Monoclonal; D003879:Dermatologic Agents; D000069285:Infliximab